Two genetic mechanisms have emerged from studies on the molecular path
ogenesis of cancer: the activation of growth-promoting oncogenes and t
he loss or inactivation of tumor suppressor genes. Both have also been
identified in tumors of the central nervous system. This contribution
summarizes the current state in the field of molecular genetics-of br
ain tumors. Many of the current research efforts are focussing on (a)
the identification of novel tumor-associated genes and gene loci, (b)
the characterization of patterns of complementary genetic changes, (c)
a molecular differentiation of morphologically homogenous tumor entit
ies and (d) the use of molecular genetic parameters as novel diagnosti
c and prognostic criteria in neuro-oncology. It is to be expected that
these studies will have a major impact on both diagnostic and clinica
l neuro-oncology.